Grail GRAL
NASDAQ GRAL
$80.77 +0.82 (+1.03%)
At close: Sep 18, 2026 · 4:00 PM EDT

Grail (GRAL) Cash & Equivalents (2023 - 2026)

Grail's (GRAL) quarterly Cash & Equivalents came in at $55.6 million in Q2 2026, down 56.33% on a YoY basis from $127.4 million in Q2 2025, and down 19.76% quarter-over-quarter from $69.3 million in Q1 2026.

Analysis

Grail (GRAL) Cash & Equivalents (2023 - 2026) Analysis & Trends

Grail (GRAL) has reported Cash & Equivalents for 4 consecutive years, with $55.6 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Cash & Equivalents fell 56.33% year-over-year to $55.6 million; the trailing twelve-month figure through Jun 2026 stood at $55.6 million (down 56.33% YoY), and the FY2025 full-year result was $249.7 million, up 16.57% from the prior year.
  • Cash & Equivalents declined to $55.6 million in Q2 2026 per GRAL's latest filing, from $69.3 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $958.8 million in Q2 2024 and bottomed at $55.6 million in Q2 2026.
  • Historically, Cash & Equivalents has averaged $266.2 million across 4 years, with a median of $143.8 million in 2023.
  • The sharpest annual moves came in 2024 and 2025: Cash & Equivalents surged 493.41% in 2024, then sank 86.71% in 2025.
  • Over 4 years, Cash & Equivalents stood at $97.3 million in 2023, then jumped by 120.21% to $214.2 million in 2024, then advanced by 16.57% to $249.7 million in 2025, then tumbled by 77.72% to $55.6 million in 2026.
  • According to Business Quant data, Cash & Equivalents over the past three periods registered $55.6 million, $69.3 million, and $249.7 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Natera 53.05 Bn 51.95 Bn 486.15 Mn 1.10 Bn
2 Quest Diagnostics 27.19 Bn 26.87 Bn 1.03 Bn 626.00 Mn
3 Labcorp Holdings 25.93 Bn 25.81 Bn 1.11 Bn 141.80 Mn
4 Guardant Health 23.97 Bn 22.91 Bn 219.03 Mn 1.05 Bn
5 Tempus AI 13.64 Bn 12.82 Bn 274.25 Mn 599.61 Mn
6 Caris Life Sciences 8.47 Bn 7.68 Bn 182.38 Mn 690.92 Mn
7 Sotera Health 5.35 Bn 4.99 Bn 177.96 Mn 356.72 Mn
8 BillionToOne 4.96 Bn 4.41 Bn 77.11 Mn 548.63 Mn
9 Adaptive Biotechnologies 4.55 Bn 4.21 Bn 51.39 Mn 169.87 Mn
10 Grail 3.61 Bn 2.75 Bn 21.34 Mn 55.65 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 55.65 Mn
Mar 31, 2026 69.34 Mn
Dec 31, 2025 249.73 Mn
Sep 30, 2025 126.90 Mn
Jun 30, 2025 127.43 Mn
Mar 31, 2025 133.90 Mn
Dec 31, 2024 214.23 Mn
Sep 30, 2024 853.55 Mn
Jun 30, 2024 958.85 Mn
Mar 31, 2024 199.72 Mn
Dec 31, 2023 97.29 Mn
Oct 1, 2023 143.84 Mn
Jun 30, 2023 230.62 Mn